Stockreport

EC OKs Roche's MS med Ocrevus [Seeking Alpha]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF EC OKs Roche's MS med OcrevusThe European Commission (EC)approves Roche's (OTCQX:RHHBY) OCREVUS (ocrelizumab) for the treatment of patients with active relapsing forms o [Read more]